{"id":"W3143019137","doi":"10.1007/s40273-021-01022-9","title":"Cost-Effectiveness Analysis of Afatinib, Erlotinib, and Gefitinib as First-Line Treatments for EGFR Mutation-Positive Non-Small-Cell Lung Cancer in Ontario, Canada","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Afatinib; Erlotinib; Gefitinib; Medicine; Lung cancer; Cost effectiveness; Internal medicine; Oncology; Epidermal growth factor receptor; Cancer registry; Cancer; Risk analysis (engineering)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001530485,0.0006677764,0.001609598,0.001315868,0.001222023,0.002072496,0.001744744,0.0009356599,0.003122146],"category_scores_gemma":[0.00742016,0.0006373562,0.003405431,0.003921093,0.0007394958,0.0005396242,0.0008588741,0.001382706,0.0001071855],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1644775,"about_ca_system_score_gemma":0.1265641,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9931995,"about_ca_topic_score_gemma":0.9958341,"domain_scores_codex":[0.9971118,0.0005937066,0.0002454679,0.0001990798,0.0009436228,0.0009062499],"domain_scores_gemma":[0.9951643,0.0008089643,0.0009805138,0.00007013308,0.001356713,0.00161938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04114483,0.002125127,0.7286238,0.006392637,0.01435523,0.001480828,0.001016146,0.06408522,0.001619781,0.005410196,0.03952103,0.09422507],"study_design_scores_gemma":[0.007507259,0.002011049,0.9409828,0.0009954011,0.007222995,0.0004506919,0.001531394,0.02910997,0.0003430973,0.0004809708,0.009199553,0.0001647176],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9463145,0.01734709,0.0003556205,0.005918067,0.0001476646,0.001019009,0.0188069,0.00004352853,0.01004763],"genre_scores_gemma":[0.9902676,0.003649237,0.0004130301,0.0006203052,0.00004112221,0.0001415837,0.003261285,0.000009134327,0.001596903],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1644775,"threshold_uncertainty_score":0.9690877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02551468580382145,"score_gpt":0.3674319987869127,"score_spread":0.3419173129830913,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}